tiprankstipranks
Trending News
More News >
Bure Equity AB (SE:BURE)
:BURE
Advertisement

Bure Equity AB (BURE) AI Stock Analysis

Compare
1 Followers

Top Page

SE:BURE

Bure Equity AB

(BURE)

Select Model
Select Model
Select Model
Neutral 58 (OpenAI - 4o)
Rating:58Neutral
Price Target:
kr261.00
▲(2.43% Upside)
Bure Equity AB's strong financial performance is the most significant factor, supported by a robust balance sheet and high profitability. However, technical indicators show bearish momentum, and valuation metrics suggest potential challenges, leading to a moderate overall score.
Positive Factors
Strong Balance Sheet
The company's low financial leverage and high equity ratio of 99.77% indicate financial stability, reducing risk and enhancing resilience.
Revenue Growth
Consistent revenue growth reflects effective portfolio management and strategic investments, supporting long-term business expansion.
High Profitability
Exceptional profitability, driven by strategic gains, enhances the company's ability to reinvest in growth and reward shareholders.
Negative Factors
Declining Cash Flows
Decreasing cash flows may limit the company's ability to fund operations and investments, potentially impacting future growth.
Reliance on Non-Operational Income
Dependence on non-operational income for profitability may pose risks if such gains are not sustainable in the long term.
Modest Revenue Compared to Previous Years
Stagnant revenue growth could indicate challenges in market expansion or competitive pressures, affecting long-term performance.

Bure Equity AB (BURE) vs. iShares MSCI Sweden ETF (EWD)

Bure Equity AB Business Overview & Revenue Model

Company DescriptionBure Equity AB (publ) is a private equity and venture capital firm specializing in secondary direct, later stage, middle market, mature, buyouts, emerging growth, expansion capital, mid venture, late venture, PIPES, bridge, industry consolidation, recapitalizations, growth capital, special situation and turnarounds. The firm has agnostic approach and seeks to invest in listed and unlisted SME companies and assets in knowledge driven service companies. It primarily invests in education service companies, communication services, medtech, consumer staples, financials, industrials, healthcare, information technology, and professional services. The firm prefers to invest in Nordic and European developed markets. It invests between $5 million to $100 million. The firm seeks to be a principal shareholder with a controlling influence in the portfolio company. The firm takes majority stake. The firm has no established exit strategy but prefers to hold its investment for a period of three to five years. It invests through its own balance sheet. Bure Equity AB (publ) was founded on November 23, 1992 and is based in Stockholm, Sweden.
How the Company Makes MoneyBure Equity AB generates revenue primarily through its investments in portfolio companies, which yield returns in the form of dividends, interest income, and capital gains upon exit. The company employs a strategy of long-term investments, enabling it to benefit from the appreciation of its holdings over time. Additionally, BURE may engage in management fees and performance-based compensation from its subsidiaries, contributing to its overall earnings. Strategic partnerships with other investment firms and industry players further bolster its financial performance, allowing for co-investing opportunities and sharing of resources to maximize returns.

Bure Equity AB Financial Statement Overview

Summary
Bure Equity AB demonstrates strong profitability with a high net profit margin and robust balance sheet characterized by minimal leverage. However, the reliance on non-operational income and declining cash flows slightly offset these strengths.
Income Statement
78
Positive
Bure Equity AB has shown strong revenue growth from 2023 to 2024 with a notable increase in total revenue by 9.05%. The company maintains an impressive net profit margin of 2381.74% for 2024, highlighting exceptional profitability, although this is largely due to significant other income or one-time gains. Gross profit margins are robust at 70.54%. EBIT and EBITDA margins are extremely high, which can be indicative of non-operational income inflating these figures. Despite these strengths, the revenue for 2024 remains modest compared to earlier years, possibly reflecting market conditions or strategic shifts.
Balance Sheet
85
Very Positive
Bure Equity AB exhibits a very strong balance sheet with a minimal debt-to-equity ratio of 0.0001, indicating low financial leverage. This is complemented by a very high equity ratio of 99.77% for 2024, showcasing financial stability and low debt reliance. The company's return on equity is remarkably high at 23.26%, driven by substantial net income. The high equity ratio and low debt levels suggest a conservative financial strategy, which enhances financial robustness and mitigates risk.
Cash Flow
72
Positive
The cash flow statement reveals mixed performance with a significant decline in operating cash flow from 2023 to 2024. Free cash flow also decreased substantially during this period. The free cash flow to net income ratio is relatively low, indicating that net income is not fully translating to cash flow. However, the company maintains positive free cash flow, supporting its operations without external funding. The operating cash flow to net income ratio suggests that operational activities contribute less to cash generation than net income, possibly due to non-operational income influencing net results.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue271.00M241.00M220.00M227.00M197.00M81.00M
Gross Profit211.00M170.00M172.00M178.00M146.00M47.00M
EBITDA-5.39B5.74B4.75B-9.23B6.36B3.30B
Net Income-5.39B5.74B4.75B-9.24B6.35B3.29B
Balance Sheet
Total Assets20.67B24.74B19.19B14.64B24.00B17.93B
Cash, Cash Equivalents and Short-Term Investments335.00M782.00M1.58B532.00M459.00M1.46B
Total Debt253.00M3.00M3.00M3.00M4.00M3.00M
Total Liabilities273.00M52.00M57.00M95.00M48.00M232.30M
Stockholders Equity20.39B24.68B19.12B14.54B23.94B17.68B
Cash Flow
Free Cash Flow190.00M172.00M1.37B160.00M958.00M45.00M
Operating Cash Flow426.00M172.00M1.37B176.00M980.00M48.00M
Investing Cash Flow-778.00M-778.00M-124.00M39.00M-1.67B-455.00M
Financing Cash Flow46.00M-201.00M-206.00M-125.00M-151.00M916.00M

Bure Equity AB Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price254.80
Price Trends
50DMA
269.62
Negative
100DMA
277.55
Negative
200DMA
295.76
Negative
Market Momentum
MACD
-5.99
Negative
RSI
43.70
Neutral
STOCH
72.49
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:BURE, the sentiment is Neutral. The current price of 254.8 is below the 20-day moving average (MA) of 255.62, below the 50-day MA of 269.62, and below the 200-day MA of 295.76, indicating a bearish trend. The MACD of -5.99 indicates Negative momentum. The RSI at 43.70 is Neutral, neither overbought nor oversold. The STOCH value of 72.49 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for SE:BURE.

Bure Equity AB Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
kr10.08B7.7712.47%2.12%4.72%-38.28%
70
Neutral
kr12.24B14.616.59%3.69%-22.65%-14.05%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
63
Neutral
€8.74B44.1515.16%11.30%-14.49%
59
Neutral
kr23.97B193.970.33%-97.64%
58
Neutral
€19.86B-6.85-23.18%1.08%22.38%-153.85%
56
Neutral
€23.97B199.46-97.64%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SE:BURE
Bure Equity AB
254.80
-113.56
-30.83%
SE:KINV.B
Kinnevik AB
87.36
11.39
14.99%
SE:RATO.B
Ratos AB
36.98
6.35
20.74%
SE:CRED.A
Creades AB
76.30
8.41
12.38%
SE:KINV.A
Kinnevik AB Class A
88.80
13.18
17.43%
SE:MCAP
MedCap AB
559.00
11.00
2.01%

Bure Equity AB Corporate Events

Bure Equity AB Faces Challenging Financial Year Amid Market Fluctuations
Nov 6, 2025

Bure Equity AB, a Swedish investment company, reported a challenging financial performance for the first nine months of 2025, with a 17.5% decrease in net asset value per share and a total return on shares of -26.7%. Despite some stabilization in the third quarter, the company faced currency struggles and lower growth, impacting its portfolio companies. Key activities included the acquisition of a stake in Silex Microsystems and divestments in Mycronic and Ovzon. The CEO noted both positive developments in companies like Vitrolife and challenges such as Yubico’s unmet expectations.

The most recent analyst rating on (SE:BURE) stock is a Hold with a SEK296.00 price target. To see the full list of analyst forecasts on Bure Equity AB stock, see the SE:BURE Stock Forecast page.

Bure Equity AB Announces Share Structure Adjustment
Sep 30, 2025

Bure Equity AB has announced a change in its share structure due to the conversion of class C shares into ordinary shares. This adjustment, aimed at fulfilling the company’s long-term incentive program, slightly alters the distribution of shares and votes, reflecting Bure’s ongoing commitment to its strategic initiatives.

The most recent analyst rating on (SE:BURE) stock is a Hold with a SEK288.00 price target. To see the full list of analyst forecasts on Bure Equity AB stock, see the SE:BURE Stock Forecast page.

Bure Equity AB Forms Nominating Committee for 2026 AGM
Sep 11, 2025

Bure Equity AB has announced the formation of its Nominating Committee for the 2026 annual general meeting, comprising representatives from its largest shareholders and the Chairman of the Board. This committee, representing 36.4% of voting shares, will play a crucial role in shaping the company’s governance and strategic direction ahead of the meeting scheduled for May 2026.

The most recent analyst rating on (SE:BURE) stock is a Hold with a SEK308.00 price target. To see the full list of analyst forecasts on Bure Equity AB stock, see the SE:BURE Stock Forecast page.

Bure Equity AB Reports Decline in Net Asset Value Amid Strategic Investments
Aug 15, 2025

Bure Equity AB reported a decrease in net asset value by 16.5% in the first half of 2025, with significant investment activities including acquiring a 17% stake in Silex Microsystems, a leader in MEMS foundry services. The company faced mixed performance from its portfolio companies, with notable growth in Mycronic and a significant order for Ovzon, while others like Vitrolife and Xvivo experienced challenges. The acquisition of Silex is seen as a strategic move to enhance growth opportunities amid geopolitical complexities.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 08, 2025